132 results on '"Khan, Muhammad Shahzeb"'
Search Results
2. From Hospital to Home: Evidence-Based Care for Worsening Heart Failure
3. Interleukin-6 and Cardiovascular Events in Healthy Adults: MESA
4. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure
5. Trends in cancer and heart failure related mortality in adult US population: A CDC WONDER database analysis from 1999 to 2020
6. Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter
7. Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries
8. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure
9. Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events
10. Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure
11. The spectrum of post-myocardial infarction care: From acute ischemia to heart failure
12. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial
13. Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment
14. Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial
15. Comparison of 30-day Readmission Rates and Inpatient Cardiac Procedures for Weekday Versus Weekend Hospital Admissions for Heart Failure
16. Association of Chronic Renal Insufficiency with Inhospital Outcomes in Primary Heart Failure Hospitalizations (Insights from the National Inpatient Sample 2004 to 2018)
17. Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3
18. Association of Non-Alcoholic Fatty Liver Disease With in-Hospital Outcomes in Primary Heart Failure Hospitalizations With Reduced or Preserved Ejection Fraction
19. An Individual Patient-Level Meta-Analysis of Ischemic Versus Nonischemic Cardiomyopathy and Trajectory of Decongestion in Patients With Acute Decompensated Heart Failure
20. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs
21. In Silico modeling and exploration of new acceptor molecules with enhanced power conversion efficiency for high-performance organic solar cell applications
22. Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk
23. Demographic and Regional Trends of Cardiovascular Diseases and Diabetes Mellitus-Related Mortality in the United States From 1999 to 2019
24. Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations
25. Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency
26. Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA
27. Management of Heart Failure With Reduced Ejection Fraction in Patients With Diabetes Mellitus and Chronic Kidney Disease
28. Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials
29. Medication-Attributable Adverse Events in Heart Failure Trials
30. Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States
31. Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review
32. Preload Reduction Therapies in Heart Failure
33. Trends in Heart Failure–Related Mortality Among Older Adults in the United States From 1999-2019
34. A Systematic Review of Sex-Specific Reporting in Heart Failure Clinical Trials: Trial Flow and Results
35. Subjective Financial Hardship due to Medical Bills Among Patients With Heart Failure in the United States: The 2014–2018 Medical Expenditure Panel Survey
36. Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018
37. The prognostic implications of ST-segment and T-wave abnormalities in patients undergoing regadenoson stress SPECT myocardial perfusion imaging
38. Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial
39. Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes
40. Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018
41. Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults
42. Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review
43. Percutaneous Mitral Valve Annuloplasty in Patients With Secondary Mitral Regurgitation and Severe Left Ventricular Enlargement
44. Clinical and Economic Burden of Stroke Among Young, Midlife, and Older Adults in the United States, 2002-2017
45. Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes
46. Rate, Causes, and Predictors of 30-Day Readmission Following Hospitalization for Acute Pericarditis
47. Early vs Late Discharge in Low-Risk ST-Elevation Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
48. Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial
49. Meta-analysis of the Relation of Body Mass Index to Cardiovascular Outcomes in Patients Receiving Intensive Low-Density Lipoprotein Cholesterol Lowering Therapy
50. Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Chronic Kidney Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.